Please login to the form below

Not currently logged in
Email:
Password:

Marstacimab

This page shows the latest Marstacimab news and features for those working in and with pharma, biotech and healthcare.

Pfizer doses first patient in investigational haemophilia drug trial

Pfizer doses first patient in investigational haemophilia drug trial

It will compare marstacimab to a run-in period on replacement therapy with VIII or IX clotting factor, respectively, or bypass therapy. ... Marstacimab offers a new way of treating haemophilia that does not rely on replacing factor VIII or factor IX.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
AMICULUM

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....